Your session is about to expire
← Back to Search
Sufentanil for Pain Management in Bleeding
Study Summary
This trial will study how well sufentanil works in reducing pain during simulated blood loss.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are there any opportunities for new patients to join this research project?
"Yes, the trial is still open and recruiting patients. According to the information available on clinicaltrials.gov, the study was posted on March 1st, 2022 and last updated on November 8th, 2022. They are looking for 30 individuals to participate at 2 different sites."
Are there any other existing studies that use Sufentanil?
"Right now, there are a total of 18 studies being conducted that involve Sufentanil. Out of those 18 studies, 5 are in Phase 3 clinical trials. The largest concentration of these research projects is located in Wuhan, Hubei; however, you can find these 26 different trial locations across the globe."
Which types of patients does this study require?
"This study will allow up to 30 individuals aged 18-45 who currently have hs to participate. In order for an individual to be eligible, they must also meet the following additional requirements: They must speak English, have a body mass greater than or equal to 65 kg, and have a BMI less than 30kg/m2."
In what ways has Sufentanil been found to be most effective?
"Sufentanil is often used to manage pain, but it can also be employed in the short-term treatment of general anesthesia, intubation (a medical procedure), and other conditions."
How many patients are being enrolled in this research project?
"That is correct. The clinical trial, which was first posted on March 1st, 2022, is still recruiting patients. 30 participants are needed from 2 different sites according to the latest information available."
Does this research project have an age limit?
"The age range for this particular trial is 18 to 45. There are a total of 112 trials for patients that are under the age of eighteen and 722 studies targeting senior citizens."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Institute for Exercise and Environmental Medicine: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger